Enacted: June 30, 1988
1st revision: September 21, 2017
2nd revision: March 7, 2018
3rd revision: March 15, 2019

AIMS AND SCHEDULES

The Journal of Trauma and Injury is an official publication of the Korean Society of Trauma and an international, peer-reviewed open access journal. The aim of this journal is to contribute to saving lives of patients who underwent traumatic events through active communication and exchange of study information on trauma and provision of education and training on trauma. For achieving aims, this journal publishes original basic and clinical researches on trauma-associated medical fields such as surgeries including general surgery, chest surgery, orthopedic surgery, neurosurgery, plastic surgery, head and neck surgery, gynecology and ophthalmology, emergency medicine, anesthesiology, neuro-psychiatrics, rehabilitation medicine and radiology including interventional radiology. Furthermore, this journal has established relationship with the Armed Forces Medical Command and Armed Forces Capital Hospital because of the Korean special situation with North Korea and publishes basic and clinical researches about the battle field trauma unique in Korea. Also this journal includes all items closely associated with medicine, disaster and department of emergency, emergency medical technicians and nurses, social infrastructures and systems, government policies and supports. The Journal of Trauma and Injury was launched in June 1988 with Korean and English Languages and has finally settled as an English language. This Journal is published four times in a year, the last day of March, June, September, and December.

GENERAL GUIDELINES

Ethical guidelines

General

This journal adheres to the ethical guidelines for research and publication described in ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’(http://www.icmje.org; International Committee of Medical Journal Editors [ICMJE]), ‘Good Publication Practice Guidelines for Medical Journals’(http://kamje.or.kr/publishing_ethics.html; Korean Association of Medical Journal Editors [KAMJE]), and ‘Guidelines on Good Publication’(http://publicationethics.org/resources/guidelines; Committee on Publication Ethics [COPE]).

Statement of human and animal right

Clinical research studies must state that the work was done in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlines in the Helsinki Declaration in 1975 (revised 2013). Clinical Studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects must not be identifiable. Patients’ name, initials, hospital number, date of birth, or other protected healthcare information must not be disclosed. Animal research studies must state that the work was performed according to National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals must be observed.

Description of participants

Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.

Authorship

All authors must have made a significant intellectual contribution to the manuscript according to the criteria formulated by the ICMJE. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors should meet criteria 1, 2, 3, and 4. General supervision of the research group is not sufficient for authorship. All authors must state they have approved the final draft submitted. Any changes to the author list after submission, such as a change in the order of the authors, or the deletion or addition of authors, needs to be approved by a letter requesting the change signed by all the authors participating.

Scope of publication

The journal publishes the original articles, case reports/ case series, review articles, editorials, correspondence, and articles commissioned by the Editorial Committee which are related to basic or clinical research on trauma.

Assurances

Informed consent

Human study must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedure must appear at the Methods section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editor-in-Chief may request a copy of the approved IRB application from the author.

Obligation to register clinical trial

Clinical trial, defined as “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome”, should be registered to the primary registry prior to publication. Journal of Trauma and Injury accepts the registration in any of the primary registries that participate in the World Health Organization (WHO) International Clinical Trials Portal (http://www.who.int/ictrp/aboutdetails/en/index.html) as well as http://actr.org.au/, http://www.clinicalgrials.gov/, http://isrctn.org/, www.umin.ac.jp/ctr/index/htm, and http://www.trialregister.nl/. The clinical trial registration number shall be published at the end of the abstract and Method section. Reporting of randomized controlled trials should follow the guidelines of the CONsolidated Standards Of Reporting Trials Statement (http://www.consort-statement.org).

Conflict of interest

The authors must acknowledge any conflict of interest they may have in the submission. The conflicts of interest may fall under any of the following categories: guarantor of the article; specific author contributions; financial support; potential competing interests.

Copyright

In view of copyright laws, accepted papers must complete the assignment forms. The papers will not be published until the copyright is complete. Korean Society of Trauma owns all the copyrights in articles published in Journal of Trauma and Injury, and all the authors are considered to have consented to the copyrights at the time of manuscript submission. The Transfer of Copyright Agreement should be submitted by all authors with initial submission of all preferred works by online at ‘http://www.jtraumainj.org/main.html’.

Originality and duplication publication

All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. Manuscripts are accepted for publication with the understanding that their contents, or their essential substance, have not been published elsewhere, except in abstract form or by the express consent of the Editors. Any part of the accepted manuscript should not be duplicated in any other scientific journal without the permission of the Editorial Board. The duplication will be checked through SimilarityCheck powered by iThenticate (https://www.crossref.org/services/similarity-check/) before review. If duplicate publication related to the papers of this journal is detected, the authors will be announced in the journal and their institutes will be informed, and there also will be penalties for the authors. Materials taken from other sources must be accompanied by written permissions for reproduction, obtained from the original publisher. Editors should follow the procedure set out in the Committee on Publication Ethics (COPE) flowcharts (https://publicationethics.org/resources/flowcharts-new/translations) that are designed to help editors follow COPE’s Code of Conduct and implement its advice when faced with cases of suspected misconduct.

Redundant publication and plagiarism

Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)”. Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subject or study populations are often the same or similar,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and their interpretation generally vary little, if at all.”
If all or part of your patient population was previously reported, this should be mentioned in the Materials and Methods, with citation of the appropriate reference(s).
All manuscripts submitted to Journal of Trauma and Injury may be screened using the iThenticate service, in conjunction with Crosscheck.

Cover letter

The cover letter should inform the editor that neither the submitted material or portions have been published previously or are under consideration for publication elsewhere. When more than one related manuscript has been published or is under consideration for publication by this or other journals, authors are required to declare this in their letter and to enclose copies of those publications for an editorial perusal. All authors have seen and approved the final manuscript. The cover letter must briefly explain each author’s individual contributions.

Preparation manuscripts

The manuscript should be written with double-line spacing and 3 cm margins on A4 sized format. Number pages consecutively, beginning from the title page.

Title page

Provide a concise title. List the full names of all authors and their institutional affiliation. In a multi-authored work involving more than a single institution, indicate individual affiliation by means of superscript Arabic numbers. Indicate a change of address in a similar fashion. List the footnotes to the title page. Provide the contact information for the corresponding author (name, address, telephone number, fax number and e-mail address), and running title less than 50 letters. Information on the research funding sources should be provided.

Abstract

Abstract of original articles must contain 300 words or less and must be organized as follows: Purpose, Methods, Results, and Conclusions. Abstract of Reviews, Case Reports/ Case Series, and Editorials must contain 250 words or less in unstructured form. Five or less key words form MeSH terms (http://www.nlm.nih.gov/mesh/meshhome.html) should be provided at the end of the abstract.

Introduction

The rationale for the study should be summarized and pertinent background material outlines. The introduction should not contain either results or conclusions. Provide the minimum background information that will orient the general reader. Do not engage in a literature review.

Methods

Methods should be described in sufficient detail so that another investigator could repeat the work. The location (manufacturer name, city, state, country) of a manufacturer listed in the text should be included. Statistical methods used should be outlined. Ethical guidelines for human or animal study should be described and approval of institutional human research review committee or animal welfare committee should be cited. Describe in detail hazardous procedures or chemicals involved, including precautions observed. Provide a level of detail such that another investigator could repeat the work. For methods that are used without significant modification, citation of the original work will suffice. Identify and provide references for all the statistical methods used.

Methods

Methods should be described in sufficient detail so that another investigator could repeat the work. The location (manufacturer name, city, state, country) of a manufacturer listed in the text should be included. Statistical methods used should be outlined. Ethical guidelines for human or animal study should be described and approval of institutional human research review committee or animal welfare committee should be cited. Describe in detail hazardous procedures or chemicals involved, including precautions observed. Provide a level of detail such that another investigator could repeat the work. For methods that are used without significant modification, citation of the original work will suffice. Identify and provide references for all the statistical methods used.

Results

Results should be presented in logical sequence in the text. Tables and illustrations and repetitive presentation of the same data in different forms should be avoided. The results should not include material appropriate to the discussion. Present the major findings of the study in graphical form if possible. Do not illustrate minor details if their message is adequately conveyed by simple descriptive text. Mention all the tables and figures.

Discussion

Discussion should explain results in relation to any hypotheses advanced in the introduction. This may include an evaluation of the methodology and of the relationship of new information to the existing corpus of knowledge in that field. Data given in the results section should not be reiterated here. Concisely present the implications of the new findings for the field as a whole, minimizing any reiteration of the results and avoid repetition of material in the introduction; keeping a close focus on the specific topic of the paper.

Conclusion

Conclusion should be deducted from results and discussions should correspond to the research goals mentioned in introduction, and should not simply summarize results. Conclusion may be omitted by summarizing its content after discussions.

Acknowledgements

If necessary, a brief acknowledgement of persons who made a genuine contribution may be included. Authors are responsible for obtaining written permission to use any copyrighted text and/or illustration.

References

(1) References should be cited in the text and listed in order in which they are first mentioned in the text.

(2) Surname should be put before given name whose first letter is capitalized. All of six or fewer authors should be recorded, and if authors are seven or more, “et al.” should be put after six authors.

(3) In principle, references should be limited to 30, 15 and 100 in an original article, case report/series and reviews, respectively.

(4) In the text, references should be cited with Arabic numerals in brackets, numbered in the order cited. In the references section, the references should be numbered and listed in order of appearance in the text.

(5) References should be arranged in Vancouver style according to citation numbers in the text (see N Engl J Med 1991;324:424-8), and the abbreviations of journals should be used according to the Index Medicus method.

i. Academic Journals: Author(s). Title. Abbreviated journal name Year;Vomune:first page-last page. Don’t add the issue numbers following volume numbers.

e.g.) Yeo KH, Park CY, Kim HH. Abdomino-perineal organ injuries caused by cultivators. JTI 2015;28:60-6.

ii. Book: Author(s). Title. Volume. Edition. City:Publisher; Year.

e.g.) Mattox KL, Moore EE, Feliciano DV. Trauma. 7th ed. New York:McGraw Hill;2013.

iii. Chapter in book: Author(s). Chapter title. In: Editor(s), ed(s). Book title. Edition. City:Publisher;Year:first page-last page.

e.g.) Burlew CC, Moore EE. Emergency department thoracotomy. In: Mattox KL, Moore EE, Feliciano DV, eds. Trauma. 7th ed. New York:McGraw Hill;2013:236-50.

iv. Website: World Health Organization (WHO). WHO statistical information system [Internet]. Geneva: WHO 2014 [cited 2014 Feb 1]. Available from: http://www.who.int/research/en/.

v. The citation of unspecified references should follow the International Committee of Medical Journal Editors, Uniform requirements for manuscripts submitted to biomedical journals (http://www.icmje.org/).

Tables

Each table must be simple and typed on a separate page with its heading above it. Explanatory matter should be placed in footnotes below the tabular matter and should not be included in the heading. All non-standard abbreviations should be explained in the footnotes, indicated by superscript-Arabic numbers. Statistical measures such as SD or SEM should be identified. Vertical rules and horizontal rules between entries should be omitted. Each table should be referred in the text consecutively and numbered according in order of citation. Tables should also be typed double-spaced, including headings. Larger size sheets must not be utilized.

Figures, illustrations and figure legends

If authors use color figures, the presentation will be enhanced. Illustrations should be sharp and presented in the TIF, BMP, or PPT format at the time of submission. Figures should be supplied in the TIF or BMP format at a final resolution of not less than 300 dpi. Do not use JPG format for clear printing. Each figure should be less than 10MB in size for electronic upload. Please contact to the Editorial Office when very large files are submitted. Microscopic pictures should be explained according to the staining method and scaled by the power of magnification (e.g., H&E stain, x400). Authors are charged for color figures.
Photographs of patients are approved when nobody cannot notice who he or she is.
Figure legends should be typed double-spaced on a separate sheet. Symbols, arrows, and letters should be used to indicate parts of illustrations. Each figure should be referred in the text consecutively and should be numbered according in order of citation.

Abbreviations

Abbreviations should be used in case that they appear in the text at least 2 times and should be explained in parentheses in its first use in the text. Do not use abbreviation in the title.

Units of measurement

Laboratory measurements should be used in SI units (International System of Units). The metric system is preferred for the expression of length, area, mass, and volume.

Special cases (Journal style)

Reviews

Review articles provide an overview of current understanding of a subject and may highlight new areas of development and discovery. These articles are limited to 5,000 words with 10 tables/figures and 100 references. A review article should be written in order of title page, abstract, keywords, introduction, main text, conclusion, acknowledgments, references, tables, and figure legends.

Case Report / Cases Series

A manuscript should be written in order of title page, abstract, keywords, introduction, case report, discussion, acknowledgments, references, tables, and figure legends.

Editorial or Correspondence

The journal welcomes readers’ comments or criticisms on articles published recently in the journal or trauma topics of interest.

Peer review and publication process

We believe that peer review is the foundation for safeguarding the quality and integrity of scientific and scholarly research. This is a guideline for reviewers who voluntarily participate in peer review process of Journal of Trauma and Injury . All of the journal's contents including commissioned manuscripts are subject to peer-review.

Double Blind Peer Review

Journal of Trauma and Injury adopts double blind review which means that the reviewer can not identify author information and authors can not identify reviewers, too.

The Role of Reviewers

Peer-reviewer’s role is to advise editors on individual manuscript to revise, accept, or reject. Judgments should be objective and comments should be lucidly described. Scientific soundness is the most important value of the journal; therefore, logic and statistical analysis should be considered meticulously. The use of reporting guideline is recommended for review. Reviewers should have no conflict of interest. Reviewers should point out relevant published work which is not yet cited. Reviewed articles are managed confidentially. The editorial office is responsible for the final decision to accept or reject a manuscript based on the reviewers' recommendation.

How to Become a Reviewer

Reviewers are usually invited by the editorial office or recommended by authors. Anyone who wants to work voluntarily as a reviewer can contact the editorial office.

Accepting an Invitation to Review

Editors invite you to review as they believe that you are an expert in a certain area. They would have judged this from your previous publication record or posters and/or sessions you have contributed to at conferences. Before you accept an invitation to review a paper, you should consider some questions:

· Are your qualified?
    If the manuscript is too far outside your area, you should decline to review it.

· Do you have time?
    If review comments cannot be submitted within the 14 days of review period, please decline to review or ask for extension of the review period.

· Are there any potential conflicts of interest?
    In case of any of the above conflicts of interest, the reviewer should decline to review. If the reviewer still wishes to review, the conflicts of interest should be specifically disclosed.

How to Write Review Comments

After entering the e-submission system with ID and password, please download PDF files and supplementary files. It is not necessary to comment on the style and format, but just concentrate on the scientific soundness and logical interpretation of the results.

• Review table with 7 items (Originality, Scientific importance, Experimental design, Adequacy of methods, Brevity and clarity, Overall priority for publication, Potential if adequately revised) is provided for the reviewer’s convenience.

• Comment to authors: Summarize the whole content of manuscript in one sentence. Mention the strengths of the manuscript, but also any problems that make you believe it should not be published, or that would need to be corrected to make it publishable.

• Comment to editor: Both the strength and shortness of the manuscript are recommended to be added. The reviewer’s recommendation on acceptance may be added here including special opinion to editor.

Ethical Guideline for Reviewers

1. Any information acquired during the review process is confidential.

2. Please inform the editor on any conflicts of interest as follows:
  • Reviewer is a competitor.
  • Reviewer may have an antipathy with the author(s).
  • Reviewer may profit financially from the work.
In case of any of the above conflicts of interest, the reviewer should decline to review. If the reviewer still wishes to review, the conflicts of interest should be specifically disclosed. A history of previous collaboration with the authors or any intimate relationship with the authors does not prohibit the review.

3. Reviewer should not use any material or data originated from the manuscript in review; however, it is possible to use open data of the manuscript after publication.

Review and publication fees

There are no author submission fees or other publication-related charges. All cost for the publication process is supported by the Publisher. Journal of Trauma and Injury is a so-called platinum open access journal which does not charge author fees.

Editor-in-Chief Gil Jae Lee

Journal of Trauma and Injury

The Korean Society of Traumatology
Department of Trauma Surgery, Gachon University Gil Medical
Center, 783 Namdong-daero, Namdong-gu, Incheon 21556, Korea
Tel: +82-10-5552-2653, Fax: +82-70-8677-6333
E-mail: trauma@kams.or.kr
Journal Homepage: http://jtraumainj.org

Copyright© The Korean Society of Traumatology. All rights reserved.
Editorial Office
783 Namdong-daero, Namdong-gu, Incheon 21556, Korea
Tel: +82-10-5552-2653   Fax: +82-70-8677-6333   E-mail: office@jtraumainj.org      Privacy Policy      Powered by M2community